Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheetSOUTH SAN FRANCISCO, Calif. and LOS ANGELES,…
Combined company to benefit from differentiated late-stage portfolio of therapies and strong balance sheet LOS ANGELES and SOUTH SAN FRANCISCO,…
RALEIGH, N.C., March 03, 2025 (GLOBE NEWSWIRE) -- Marius Pharmaceuticals, is pleased to announce that the U.S. Food and Drug…
LSPedia's OneScan Suite Transforms Healthcare Operations with Seamless FDA DSCSA Compliance, Integration, and Unmatched Supply Chain Insights. FARMINGTON HILLS, Mich.,…
SEAL Future Foundation joins forces to expand safe access to psychedelic-assisted therapies “Guidance Integration Platform” to provide integration resources for…
HOUSTON, TX, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader…
On track to announce the primary endpoint result from the atacicept pivotal Phase 3 ORIGIN trial in IgA Nephropathy (IgAN)…
CHICAGO, Feb. 25, 2025 /PRNewswire/ -- RedMane Technology today released a white paper focusing on the crucial role AI can…
BELFAST, Northern Ireland, Feb. 24, 2025 /PRNewswire/ -- Neurovalens, a global leader in noninvasive neurostimulation technology, is making significant strides…
SCOTTSDALE, Ariz., Feb. 20, 2025 /PRNewswire/ -- GlobalMed, a global leader in digital health solutions, is proud to announce a…